Page last updated: 2024-08-24

2-amino-3-methyl-9h-pyrido(2,3-b)indole and Precancerous Conditions

2-amino-3-methyl-9h-pyrido(2,3-b)indole has been researched along with Precancerous Conditions in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hasegawa, R; Ito, N; Iwasaki, S; Kim, DJ; Nagao, M; Ochiai, M; Shirai, T; Sugimura, T; Takahashi, S1

Other Studies

1 other study(ies) available for 2-amino-3-methyl-9h-pyrido(2,3-b)indole and Precancerous Conditions

ArticleYear
Dose-dependent formation of preneoplastic foci and DNA adducts in rat liver with 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeA alpha C) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
    Carcinogenesis, 1992, Volume: 13, Issue:8

    Topics: Animals; Carbolines; DNA; DNA Damage; Dose-Response Relationship, Drug; Glutathione Transferase; Imidazoles; Liver; Liver Neoplasms, Experimental; Male; Mutagens; Precancerous Conditions; Rats; Rats, Inbred F344

1992